Filter the drugs by their status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Latest database update
Number of references
Tocilizumab Recommended by China's NHC Guidelines Used to treat other disease Other treatment Oct/24/2020 Oct/27/2020 0
Favipiravir Approved for COVID-19 treatment (China, India, Russia) Used to treat other disease Antiviral Oct/20/2020 Oct/26/2020 0
Remdesivir Approved by FDA Experimental Antiviral Oct/20/2020 Oct/29/2020 0
Lopinavir Recommended by China's NHC Guidelines Used to treat other disease Antiviral Oct/15/2020 Oct/16/2020 0
Emetine Potential treatment - pre-clinical evidence Experimental Antiviral Sep/25/2020 Oct/24/2020 0
Mefloquine hydrochloride Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Sep/08/2020 Oct/04/2020 0
NVX-CoV2373 Potential treatment - clinical evidence Experimental Vaccine Sep/02/2020 Sep/25/2020 0
Amodiaquine Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Aug/19/2020 Sep/04/2020 0
BNT162b1 Potential treatment - clinical evidence Experimental Vaccine Aug/12/2020 Aug/26/2020 0
S1-Fc vaccine Potential treatment - pre-clinical evidence Experimental Vaccine Jul/31/2020 Sep/02/2020 0